Heartland Advisors Inc Abbott Laboratories Transaction History

Heartland Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $4.67 Million - $5.64 Million	-70,463 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $76,377 - $86,524	-1,165 Reduced 1.63%	70,463 $5.1 Million
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $47,310 - $57,074	-778 Reduced 1.07%	71,628 $5.26 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $62,175 - $68,623	-1,080 Reduced 1.47%	72,406 $4.42 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $883,720 - $999,152	-15,705 Reduced 17.61%	73,486 $4.4 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $20,452 - $21,896	381 Added 0.43%	89,191 $5.09 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $4.27 Million - $4.76 Million	88,810	88,810 $4.74 Million

3,208

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Heartland Advisors Inc with notifications on news.